Cite
HARVARD Citation
Thota, P. et al. (2022). Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma. Journal of clinical gastroenterology. 56 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Thota, P. et al. (2022). Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma. Journal of clinical gastroenterology. 56 (2), p. . [Online].